LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | WZ-4-145 | 0.12 | uM | LJP6 | 1 | J23 | 72 | hr | 868 | 3020 | 3486 | 0.8662 | 0.8219 |
MDA-MB-231 | WZ-4-145 | 0.12 | uM | LJP6 | 2 | J23 | 72 | hr | 868 | 2900 | 3486 | 0.8318 | 0.7760 |
MDA-MB-231 | WZ-4-145 | 0.12 | uM | LJP6 | 3 | J23 | 72 | hr | 868 | 2885 | 3486 | 0.8275 | 0.7703 |
MDA-MB-231 | XMD16-144 | 0.12 | uM | LJP5 | 1 | M11 | 72 | hr | 868 | 1344 | 3486 | 0.3855 | 0.1818 |
MDA-MB-231 | XMD16-144 | 0.12 | uM | LJP5 | 2 | M11 | 72 | hr | 868 | 1310 | 3486 | 0.3758 | 0.1688 |
MDA-MB-231 | XMD16-144 | 0.12 | uM | LJP5 | 3 | M11 | 72 | hr | 868 | 1221 | 3486 | 0.3502 | 0.1348 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 868 | 2902 | 3486 | 0.8324 | 0.7768 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 868 | 2917 | 3486 | 0.8367 | 0.7825 |
MDA-MB-231 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 868 | 2595 | 3486 | 0.7443 | 0.6596 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 868 | 3356 | 3486 | 0.9626 | 0.9502 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 868 | 3442 | 3486 | 0.9873 | 0.9830 |
MDA-MB-231 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 868 | 3479 | 3486 | 0.9979 | 0.9972 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 1 | L23 | 72 | hr | 868 | 3019 | 3486 | 0.8659 | 0.8215 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 2 | L23 | 72 | hr | 868 | 3233 | 3486 | 0.9273 | 0.9032 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 3 | L23 | 72 | hr | 868 | 3265 | 3486 | 0.9365 | 0.9154 |
MDA-MB-231 | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 868 | 3084 | 3486 | 0.8846 | 0.8463 |
MDA-MB-231 | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 868 | 3660 | 3486 | 1.0498 | 1.0663 |
MDA-MB-231 | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 868 | 3407 | 3486 | 0.9772 | 0.9697 |
MDA-MB-231 | Celastrol | 0.12 | uM | LJP6 | 1 | G11 | 72 | hr | 868 | 3621 | 3486 | 1.0386 | 1.0514 |
MDA-MB-231 | Celastrol | 0.12 | uM | LJP6 | 2 | G11 | 72 | hr | 868 | 3659 | 3486 | 1.0495 | 1.0659 |
MDA-MB-231 | Celastrol | 0.12 | uM | LJP6 | 3 | G11 | 72 | hr | 868 | 3926 | 3486 | 1.1261 | 1.1679 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP5 | 1 | F05 | 72 | hr | 868 | 950 | 3486 | 0.2725 | 0.0313 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP5 | 2 | F05 | 72 | hr | 868 | 903 | 3486 | 0.2590 | 0.0133 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP5 | 3 | F05 | 72 | hr | 868 | 986 | 3486 | 0.2828 | 0.0450 |
MDA-MB-231 | CGP60474 | 0.12 | uM | LJP6 | 1 | G05 | 72 | hr | 868 | 775 | 3486 | 0.2223 | -0.0356 |